Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. (Q38035670)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 August 2012

Language	Label	Description	Also known as
English	Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.	scientific article published on 15 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1 reference

based on heuristic

inferred from title

Hepatitis B vaccine

1 reference

based on heuristic

inferred from title

Corinna Klingler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Andrea I Thoumi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Vinod S Mrithinjayam

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

15 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

252-259

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa--too soon?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Long-term follow-up of hepatitis B vaccine in infants of carrier mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Natural history of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

The e antigen and vertical transmission of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Risks of chronicity following acute hepatitis B virus infection: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

The influence of age on the development of the hepatitis B carrier state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Disability-adjusted life years: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Understanding DALYs (disability-adjusted life years)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.007

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.08.007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22902676%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38035670&oldid=1566765854"